MARKET DEFINITION

Guided Bone Regeneration is a surgical procedure which involves the placement of cell-occluive physical barrier, either resorbable or non-resorbable between the connective tissue and the alveolar bone defect. The procedure is done to aid the bone regeneration process. That has evolved from guided tissue regeneration. It is used to increase bone volume in the areas of bone resorption, facilitating implant placement and long term stability. Conditions such as chonic periodontal disease, chronic edentulous dental arches, alveolar bone defects require guided bone regeneration procedures.

MARKET DYNAMICS

The market for dental guided bone regeneration membranes will expand as a result of rising dental implant demand and rising instances of periodontal disease and oral cancer. Manufacturers will also speed up market expansion by stepping up product development and putting more of an emphasis on supplying the demand for efficient treatments. In the coming years, demand for guided bone regeneration is anticipated to grow as the population in emerging nations like India, Japan, Australia, among others become more aware of dental implant techniques. One of the biggest markets for dental implants is India. Furthermore, introduction of latest technologies in the dental implant industry will provide lucrative growth opportunities to the key players in this market. However, the higher costs associated with the dental procedures and lack of favorable insurance coverage are some of the factors which might hinder the market growth.

REPORT SCOPE

The report titled “Global Guided Bone Regeneration Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Guided Bone Regeneration market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global guided bone regeneration market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global guided bone regeneration market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION

The Global Guided Bone Regeneration Market is segmented based on barrier membrane type, indication, end user and region. The barrier membrane type segment categorizes the market into non-resorbable membranes and resorbable membranes. The non-resorbable membranes are further divided into expanded polytetrafluoroethylene (e-PTFE), high-density polytetrafluoroethylene (d-PTFE), and titanium mesh and titanium-reinforced PTFE. The resorbable membranes are further divided into polyglycoside synthetic copolymers, collagen, and calcium sulfate. Based on indication, the market is segmented into fenestration & dehiscence, socket preservation, post cystectomy, sinus lift elevation prior to implant placement, and pre-implant therapy. Based on end user, the market is categorized into dental clinics, implants centers, and academic & research centers.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the guided bone regeneration market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global guided bone regeneration market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global guided bone regeneration market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Guided Bone Regeneration industry in the past three years.

Key players in the Global Guided Bone Regeneration Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• ACE Surgical
• BEGO
• Bioteck
• Biotiss Biomaterials
• Danher Corporation
• Dentegris
• Dentsply Sirona
• Geistlich
• Genoss
• Keystone Dental
• Neoss Limited
• OraPharma
• Orthocell
• OssTem
• Sunstar
• Yantai Zhenghai Bio-tech Co. Ltd.
• Zimmer Biomet Holdings

COVID-19 IMPACT ANALYSIS ON GLOBAL GUIDED BONE REGENERATION MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

1. What is the current size of the global guided bone regeneration market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the guided bone regeneration market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:

• The report offers comprehensive data on the guided bone regeneration market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
• The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity

Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective

Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Barrier Membrane Type Trends
3.2.2. Indication Trends
3.2.3. End User Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Guided Bone Regeneration Market
3.6. COVID-19 Impact Assessment in Guided Bone Regeneration Market
3.6.1. Impact Assessment on Global Guided Bone Regeneration Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4. Global Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
4.1. Global Guided Bone Regeneration Market Share, By Barrier Membrane Type, 2017 - 2028 (USD Million)
4.1.1. Non-resorbable membranes
4.1.1.1. Expanded polytetrafluoroethylene (e-PTFE)
4.1.1.2. High-density polytetrafluoroethylene (d-PTFE)
4.1.1.3. Titanium mesh and titanium-reinforced PTFE
4.1.2. Resorbable Membranes
4.1.2.1. Polyglycoside synthetic copolymers
4.1.2.2. Collagen
4.1.2.3. Calcium sulfate

Chapter 5. Global Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
5.1. Global Guided Bone Regeneration Market Share, By Indication, 2017 - 2028 (USD Million)
5.1.1. Fenestration & Dehiscence
5.1.2. Socket Preservation
5.1.3. Post Cystectomy
5.1.4. Sinus Lift Elevation prior to implant placement
5.1.5. Pre-Implant Therapy

Chapter 6. Global Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
6.1. Global Guided Bone Regeneration Market Share, By End User, 2017 - 2028 (USD Million)
6.1.1. Dental Clinics
6.1.2. Implant Centers
6.1.3. Academic & Research Centers

Chapter 7. Global Guided Bone Regeneration Market Overview, By Geography, 2017 - 2028 (USD Million)
7.1. Global Guided Bone Regeneration Market Share, By Geography, 2017 - 2028 (USD Million)
7.1.1. Market Size and Projections, by Countries, 2017 - 2028 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 8. North America Guided Bone Regeneration Market Overview, By Countries, 2017 - 2028 (USD Million)
8.1. North America Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
8.1.1. Market size and projections, 2017 - 2028 (USD Million)
8.1.2. North America Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
8.1.3. North America Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
8.1.4. North America Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
8.2. North America Guided Bone Regeneration Market Overview, By Countries, 2017 - 2028 (USD Million)
8.2.1. U.S. Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
8.2.1.1. U.S. Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
8.2.1.2. U.S. Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
8.2.1.3. U.S. Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
8.2.2. Canada Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
8.2.2.1. Canada Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
8.2.2.2. Canada Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
8.2.2.3. Canada Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
8.2.3. Mexico Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
8.2.3.1. Mexico Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
8.2.3.2. Mexico Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
8.2.3.3. Mexico Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)

Chapter 9. Europe Guided Bone Regeneration Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. Europe Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market size and projections, 2017 - 2028 (USD Million)
9.1.2. Europe Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
9.1.3. Europe Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
9.1.4. Europe Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
9.2. Europe Guided Bone Regeneration Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. Germany Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. Germany Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
9.2.1.2. Germany Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.1.3. Germany Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.2. France Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. France Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
9.2.2.2. France Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.2.3. France Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.3. UK Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. UK Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
9.2.3.2. UK Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.3.3. UK Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.4. Italy Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
9.2.4.1. Italy Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
9.2.4.2. Italy Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.4.3. Italy Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.5. Spain Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
9.2.5.1. Spain Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
9.2.5.2. Spain Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.5.3. Spain Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.6. NORDIC Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
9.2.6.1. NORDIC Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
9.2.6.2. NORDIC Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.6.3. NORDIC Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.7. Russia and CIS Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
9.2.7.1. Russia and CIS Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
9.2.7.2. Russia and CIS Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.7.3. Russia and CIS Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.8. Rest of Europe Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
9.2.8.1. Rest of Europe Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
9.2.8.2. Rest of Europe Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.8.3. Rest of Europe Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)

Chapter 10. Asia Pacific Guided Bone Regeneration Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. Asia Pacific Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market size and projections, 2017 - 2028 (USD Million)
10.1.2. Asia Pacific Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
10.1.3. Asia Pacific Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
10.1.4. Asia Pacific Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
10.2. Asia Pacific Guided Bone Regeneration Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. India Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. India Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
10.2.1.2. India Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.1.3. India Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.2. China Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. China Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
10.2.2.2. China Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.2.3. China Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.3. Japan Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. Japan Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
10.2.3.2. Japan Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.3.3. Japan Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.4. ASEAN Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
10.2.4.1. ASEAN Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
10.2.4.2. ASEAN Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.4.3. ASEAN Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.5. South Korea Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
10.2.5.1. South Korea Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
10.2.5.2. South Korea Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.5.3. South Korea Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.6. Australia Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
10.2.6.1. Australia Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
10.2.6.2. Australia Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.6.3. Australia Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.7. Rest of Asia Pacific Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
10.2.7.1. Rest of Asia Pacific Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
10.2.7.2. Rest of Asia Pacific Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.7.3. Rest of Asia Pacific Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)

Chapter 11. South America Guided Bone Regeneration Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. South America Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market size and projections, 2017 - 2028 (USD Million)
11.1.2. South America Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
11.1.3. South America Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
11.1.4. South America Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
11.2. South America Guided Bone Regeneration Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. Brazil Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. Brazil Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
11.2.1.2. Brazil Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.1.3. Brazil Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.2. Argentina Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. Argentina Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
11.2.2.2. Argentina Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.2.3. Argentina Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.3. Rest of South America Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Rest of South America Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
11.2.3.2. Rest of South America Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.3.3. Rest of South America Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)

Chapter 12. Middle East & Africa Guided Bone Regeneration Market Overview, By Countries, 2017 - 2028 (USD Million)
12.1. Middle East & Africa Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
12.1.1. Market size and projections, 2017 - 2028 (USD Million)
12.1.2. Middle East & Africa Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
12.1.3. Middle East & Africa Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
12.1.4. Middle East & Africa Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
12.2. Middle East & Africa Guided Bone Regeneration Market Overview, By Countries, 2017 - 2028 (USD Million)
12.2.1. GCC Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
12.2.1.1. GCC Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
12.2.1.2. GCC Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.1.3. GCC Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
12.2.2. South Africa Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
12.2.2.1. South Africa Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
12.2.2.2. South Africa Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.2.3. South Africa Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)
12.2.3. Rest of Middle East & Africa Guided Bone Regeneration Market Overview, 2017 - 2028 (USD Million)
12.2.3.1. Rest of Middle East & Africa Guided Bone Regeneration Market Overview, By Barrier Membrane Type, 2017 - 2028 (USD Million)
12.2.3.2. Rest of Middle East & Africa Guided Bone Regeneration Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.3.3. Rest of Middle East & Africa Guided Bone Regeneration Market Overview, By End User, 2017 - 2028 (USD Million)

Chapter 13. Competitive Landscape
13.1. Competitive Environment, 2021
13.2. Strategic Framework
13.2.1. Partnership/Collaborations/Agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Product Development

Chapter 14. Key Vendor Analysis
14.1. ACE Surgical
14.1.1. Business Overview
14.1.2. Product Benchmarking
14.1.3. Financial Data
14.1.4. Strategic Overview
14.1.5. Key Developments
14.1.6. SWOT Analysis
14.2. BEGO
14.2.1. Business Overview
14.2.2. Product Benchmarking
14.2.3. Financial Data
14.2.4. Strategic Overview
14.2.5. Key Developments
14.2.6. SWOT Analysis
14.3. Bioteck
14.3.1. Business Overview
14.3.2. Product Benchmarking
14.3.3. Financial Data
14.3.4. Strategic Overview
14.3.5. Key Developments
14.3.6. SWOT Analysis
14.4. Biotiss Biomaterials
14.4.1. Business Overview
14.4.2. Product Benchmarking
14.4.3. Financial Data
14.4.4. Strategic Overview
14.4.5. Key Developments
14.4.6. SWOT Analysis
14.5. Danaher Corporation
14.5.1. Business Overview
14.5.2. Product Benchmarking
14.5.3. Financial Data
14.5.4. Strategic Overview
14.5.5. Key Developments
14.5.6. SWOT Analysis
14.6. Dentegris
14.6.1. Business Overview
14.6.2. Product Benchmarking
14.6.3. Financial Data
14.6.4. Strategic Overview
14.6.5. Key Developments
14.6.6. SWOT Analysis
14.7. Dentsply Sirona
14.7.1. Business Overview
14.7.2. Product Benchmarking
14.7.3. Financial Data
14.7.4. Strategic Overview
14.7.5. Key Developments
14.7.6. SWOT Analysis
14.8. Geistlich
14.8.1. Business Overview
14.8.2. Product Benchmarking
14.8.3. Financial Data
14.8.4. Strategic Overview
14.8.5. Key Developments
14.8.6. SWOT Analysis
14.9. Genoss
14.9.1. Business Overview
14.9.2. Product Benchmarking
14.9.3. Financial Data
14.9.4. Strategic Overview
14.9.5. Key Developments
14.9.6. SWOT Analysis
14.10. Keystone Dental
14.10.1. Business Overview
14.10.2. Product Benchmarking
14.10.3. Financial Data
14.10.4. Strategic Overview
14.10.5. Key Developments
14.10.6. SWOT Analysis
14.11. Neoss Limited
14.11.1. Business Overview
14.11.2. Product Benchmarking
14.11.3. Financial Data
14.11.4. Strategic Overview
14.11.5. Key Developments
14.11.6. SWOT Analysis
14.12. OraPharma
14.12.1. Business Overview
14.12.2. Product Benchmarking
14.12.3. Financial Data
14.12.4. Strategic Overview
14.12.5. Key Developments
14.12.6. SWOT Analysis
14.13. Orthocell
14.13.1. Business Overview
14.13.2. Product Benchmarking
14.13.3. Financial Data
14.13.4. Strategic Overview
14.13.5. Key Developments
14.13.6. SWOT Analysis
14.14. OssTem
14.14.1. Business Overview
14.14.2. Product Benchmarking
14.14.3. Financial Data
14.14.4. Strategic Overview
14.14.5. Key Developments
14.14.6. SWOT Analysis
14.15. Sunstar
14.15.1. Business Overview
14.15.2. Product Benchmarking
14.15.3. Financial Data
14.15.4. Strategic Overview
14.15.5. Key Developments
14.15.6. SWOT Analysis
14.16. Yantai Zhenghai Bio-tech Co. Ltd.
14.16.1. Business Overview
14.16.2. Product Benchmarking
14.16.3. Financial Data
14.16.4. Strategic Overview
14.16.5. Key Developments
14.16.6. SWOT Analysis
14.17. Zimmer Biomet Holdings
14.17.1. Business Overview
14.17.2. Product Benchmarking
14.17.3. Financial Data
14.17.4. Strategic Overview
14.17.5. Key Developments
14.17.6. SWOT Analysis

Chapter 15. Future Outlook of the Market
Disclaimer